Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.53USD
9:10pm BST
Change (% chg)

$-0.05 (-1.40%)
Prev Close
$3.58
Open
$3.59
Day's High
$3.59
Day's Low
$3.47
Volume
19,091
Avg. Vol
50,662
52-wk High
$4.68
52-wk Low
$2.33

O'Brien, James 

Mr. James M. O'Brien is an Executive Vice President - Finance of the Company. From 2010 to 2013, Mr. O’Brien was Vice President and Corporate Controller for Allergen, plc. (formally Actavis, plc) a global specialty pharmaceutical company. From 1998 to 2010, Mr. O’Brien held senior level finance leadership roles at Nycomed US, Aptuit, Inc., Purdue Pharma LLP and Bristol Myers Squibb Company. From 1988 to 1998, Mr. O’Brien was with PricewaterhouseCoopers LLP. He received his Bachelor of Accounting degree from George Washington University and his Master of Business Administration from Fordham University. Mr. O’Brien is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 317,000
Restricted Stock Award, USD 17,680
Long-Term Incentive Plans, USD --
All Other, USD 160,042
Fiscal Year Total, USD 494,722

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018